Y. Mukadi

发表

Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries

Ross J. Harris, L. Rotz, R. Chaisson, 2015, European Respiratory Journal.

Lower Levels of Antiretroviral Therapy Enrollment Among Men with HIV Compared with Women - 12 Countries, 2002-2013.

A. Abdul-Quader, C. Hamilton, F. Wabwire-mangen, 2015, MMWR. Morbidity and mortality weekly report.

Genetic sequencing for surveillance of drug resistance in tuberculosis in highly endemic countries: a multi-country population-based surveillance study

D. Chin, K. Floyd, L. Rigouts, 2018, The Lancet. Infectious diseases.

Population-based resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones: results from a multicountry surveillance project

K. Floyd, L. Rigouts, S. Niemann, 2016, The Lancet. Infectious diseases.

How human immunodeficiency virus voluntary testing can contribute to tuberculosis control.

D. Maher, M. Raviglione, P. Nunn, 2002, Bulletin of the World Health Organization.

Trend in HIV prevalence among tuberculosis patients in Tanzania, 1991-1998.

S. Egwaga, N. Range, R. O'brien, 2001, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Reasons for Missing Antiretroviral Therapy: Results from a Multi-Country Study in Tanzania, Uganda, and Zambia

F. Wabwire-mangen, D. Bangsberg, J. Menten, 2016, PloS one.

Incomplete adherence among treatment-experienced adults on antiretroviral therapy in Tanzania, Uganda and Zambia

F. Wabwire-mangen, D. Bangsberg, J. Menten, 2015, AIDS.

Tuberculosis and HIV infection: implications for Africa.

P. Nunn, Y. Mukadi, J. Perriëns, 1991, AIDS.

Outbreak of Tuberculosis and Multidrug-Resistant Tuberculosis, Mbuji-Mayi Central Prison, Democratic Republic of the Congo

B. D. de Jong, M. Boelaert, Y. Mukadi, 2018, Emerging infectious diseases.

Adherence Support Workers: A Way to Address Human Resource Constraints in Antiretroviral Treatment Programs in the Public Health Setting in Zambia

Y. Mukadi, A. Mwango, K. Torpey, 2008, PloS one.

Increasing the uptake of prevention of mother-to-child transmission of HIV services in a resource-limited setting

Y. Mukadi, P. Kasonde, K. Torpey, 2010, BMC health services research.

Antiretroviral Therapy Enrollment Characteristics and Outcomes Among HIV-Infected Adolescents and Young Adults Compared with Older Adults — Seven African Countries, 2004–2013

C. Hamilton, F. Wabwire-mangen, D. Bangsberg, 2014, MMWR. Morbidity and mortality weekly report.

Prevention of mother-to-child transmission of HIV in Zambia: implementing efficacious ARV regimens in primary health centers

Y. Mukadi, J. Mandala, P. Kasonde, 2009, BMC public health.

Initiating antiretroviral treatment in a resource-constrained setting: does clinical staging effectively identify patients in need?

R. Colebunders, Y. Mukadi, M. Lartey, 2009, International journal of STD & AIDS.

Tuberculosis case fatality rates in high HIV prevalence populations in sub-Saharan Africa

A. Harries, D. Maher, Y. Mukadi, 2001, AIDS.

Differences Between HIV-Infected Men and Women in Antiretroviral Therapy Outcomes — Six African Countries, 2004–2012

C. Hamilton, F. Wabwire-mangen, D. Bangsberg, 2013, MMWR. Morbidity and mortality weekly report.

How human immunodeficiency virus voluntary testing can contribute to tuberculosis control.

Dermot Maher, Paul Nunn, D. Maher, 2002, Bulletin of the World Health Organization.

GeneXpert for TB diagnosis: planned and purposeful implementation

T. Shinnick, W. Coggin, Y. Mukadi, 2013, Global Health: Science and Practice.

Translational Research for Tuberculosis Elimination: Priorities, Challenges, and Actions

S. Swaminathan, F. Cobelens, G. Kaplan, 2016, PLoS medicine.

Retention and risk factors for attrition among adults in antiretroviral treatment programmes in Tanzania, Uganda and Zambia

F. Wabwire-mangen, D. Bangsberg, J. Menten, 2014, Tropical medicine & international health : TM & IH.

Bedaquiline, Delamanid, Linezolid, and Clofazimine for Treatment of Pre-extensively Drug-Resistant Tuberculosis

Gayathri, Muthukumar, Tamizharasan, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Potential utility of empirical tuberculosis treatment for HIV-infected patients with advanced immunodeficiency in high TB-HIV burden settings.

S. Egwaga, S. Lawn, A. Harries, 2011, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Normal CD4+ T lymphocyte levels in HIV seronegative individuals in the Manya/Yilo Krobo communities in the Eastern region of Ghana.

Y. Mukadi, K. Koram, Kisten Nolan, 2006, Viral immunology.

Track C Epidemiology and Prevention Science

David R. Holtgrave, W. Heneine, Y. Nakamura, 2012, Journal of the International AIDS Society.

How human immunodeficiency virus voluntary testing can contribute to tuberculosis control.

D. Maher, M. Raviglione, P. Nunn, 2002, Bulletin of the World Health Organization.

Meeting the 2030 END TB goals in the wake of COVID-19: A modelling study of countries in the USAID TB portfolio

N. Arinaminpathy, Y. Mukadi, S. Ahmedov, 2022, medRxiv.

Differences Between HIV-Infected Men and Women in Antiretroviral Therapy Outcomes — Six African Countries, 2004–2012

C. Hamilton, F. Wabwire-mangen, D. Bangsberg, 2013, MMWR. Morbidity and mortality weekly report.

A retrospective cohort study of the risk of tuberculosis among women of childbearing age with HIV infection in Zaire.

M. M. Braun, N. Badi, R. Ryder, 1991, The American review of respiratory disease.